950846-26-1

Basic information

• Product Name: (4-Bromo-2,5-dimethoxyphenyl)boronic acid
• Synonyms: B-(4-Bromo-2,5-dimethoxyphenyl)boronic acid
• CAS NO: 950846-26-1
• Molecular Formula: C8H10BBrO4
• Molecular Weight: 260.8776
• Mol File: 950846-26-1.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: (4-Bromo-2,5-dimethoxyphenyl)boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (4-Bromo-2,5-dimethoxyphenyl)boronic acid(950846-26-1)
• EPA Substance Registry System: (4-Bromo-2,5-dimethoxyphenyl)boronic acid(950846-26-1)

Safety Data

• Hazardous Substances Data: 950846-26-1(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(4-Bromo-2,5-dimethoxyphenyl)boronic acid is used as a reagent in organic synthesis for the formation of carbon-carbon bonds through the Suzuki coupling reaction. This reaction is a powerful tool in constructing complex organic molecules and is widely used in the synthesis of biologically active compounds and materials.
Used in Pharmaceutical Production:
In the pharmaceutical industry, (4-Bromo-2,5-dimethoxyphenyl)boronic acid is used as a key intermediate in the synthesis of various drugs. Its ability to form carbon-carbon bonds makes it a valuable component in the development of new pharmaceuticals with improved efficacy and selectivity.
Used in Agrochemical Production:
Similarly, in the agrochemical industry, (4-Bromo-2,5-dimethoxyphenyl)boronic acid is employed as an intermediate in the synthesis of pesticides and other agrochemicals. Its use contributes to the development of more effective and environmentally friendly products for agricultural applications.
Used in the Development of Novel Materials:
(4-Bromo-2,5-dimethoxyphenyl)boronic acid is also utilized in the research and development of new materials and functional molecules. Its unique properties and reactivity make it a promising candidate for creating innovative materials with potential applications in various fields, such as electronics, energy, and medicine.

Upstream product

• 5419-55-6 Triisopropyl borate 
• 2674-34-2 1,4-dibromo-2,5-dimethoxybenzene 
• 150-78-7 1,4-dimethoxybezene 
• 121-43-7 Trimethyl borate 

Relevant articles and documents

5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION

The present invention relates to agonists of the 5-HT2A serotonin receptors and their medical uses. In one aspect the invention relates to 5-HT2A agonists of formula (I). In second aspect, the invention relates to selective 5-HT2A agonists of formula (II). In another aspect, the invention relates to mixed 5-HT2A/5-HT2C agonists of formula (III). In yet another aspect, the invention relates to 5-HT2A agonists for use in the treatment of a depressive disorder, more particular a 5-HT2A agonist for the use in the treatment of treatment-resistant depression.

Side functionalization of diboronic acid precursors for covalent organic frameworks

A series of substituted 1,4-benzenediboronic acids (BDBA) was synthesized and their thermal properties investigated. Two diboronic acids were studied as building-blocks for covalent organic framework (COF) formation, namely 2,5-dimethoxy-1,4-benzenediboronic acid and 2-nitro-1,4-benzeneboronic acid. Interestingly, substitution of the BDBA core caused a dramatic decrease of the polymerization temperature leading to the formation of a less organized structure.

Aryl trihydroxyborate salts: Thermally unstable species with unusual gelation abilities

A series of aryl trihydroxyborate salts were synthesized and found to form gels in benzene. The compounds were thermally unstable and readily underwent protodeboronation in solution and the solid state. Gelation could be induced without decomposition via sonication. Subsequent characterization studies revealed an unusual dependence of gel properties on alkyl chain length.

2-AMIN0-5, 7-DIHYDR0-6H- PYRROLO [3, 4-D] PYRIMIDINE DERIVATIVES AS HSP-90 INHIBITORS FOR TREATING CANCER

The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors.

Synthesis of penta-p-phenylenes with oligo(ethylene glycol) side chains

We report an efficient synthesis of a series of penta-p-phenylene derivatives with four side chains of various lengths, including deca(ethylene glycol) groups. The key feature of the synthesis is that the side chains are efficiently introduced in the last step, facilitating optimization of the side chains for different applications. Raman spectroscopy study indicates a similarly high rigidity for all these compounds, even those with long oligo(ethylene glycol) side chains. The deca(ethylene glycol)-substituted penta-p-phenylene derivatives are versatile building blocks for construction of nanometric, tripod-shaped adsorbates for biological applications.